<ruby id="zqerw"><i id="zqerw"><strike id="zqerw"></strike></i></ruby>
  • <small id="zqerw"><del id="zqerw"></del></small>

    產品資料

    人血管生成素-1|Human ANG-1

    產品名稱: 人血管生成素-1|Human ANG-1
    產品型號: C02-130-06-20ug
    產品展商: peprotech
    產品文檔: 無相關文檔

    簡單介紹

    人血管生成素-1|Human ANG-1系列產品主要適用于試驗室或生化科研相關試驗,CANSPEC品質提供人血管生成素-1|Human ANG-1性能**,中文名稱為人血管生成素-1|Human ANG-1。產品人血管生成素-1|Human ANG-1以其優良的品質滿足您不同科研實驗的多種需求。


    人血管生成素-1|Human ANG-1  的詳細介紹

    產品名稱:人血管生成素-1|Human ANG-1

    產品規格:

    C02-130-06-20ug人血管生成素-1|Human ANG-120ug¥1,960
    C02-130-06-5ug人血管生成素-1|Human ANG-15ug¥680

    單        位:瓶

    關 鍵 字:人血管生成素-1|Human ANG-1


    CANSPEC品質提供的人血管生成素-1|Human ANG-1性能**,英文名稱人血管生成素-1|Human ANG-1,簡稱為人血管生成素-1|Human ANG-1,中文名稱為人血管生成素-1|Human ANG-1 。

    產品人血管生成素-1|Human ANG-1以其優良的品質滿足您不同實驗的多種需求。并保證每批人血管生成素-1|Human ANG-1的質量和人血管生成素-1|Human ANG-1 品質優良。

    Synonyms :

    Angiopoietin-1

    Description :

    Angiopoietin-1 (Ang-1) is a secreted ligand for Tie-2, a tyrosine-kinase receptor expressed primarily on vascular endothelial cells and early hematopoietic cells. Ang-1/ Tie-2 signaling promotes angiogenesis during the development, remodeling, and repair of the vascular system. Transgenic mice lacking expression of either Ang-1 or Tie-2 fail to develop a fully functional cardiovascular system and die before birth. Postnatally, the angiogenic activity of Ang-1/Tie-2 is required during normal tissue repair and remodeling of the female endometrium in the menstrual cycle. Ang-1/Tie-2 signaling appears to be regulated by Angiopoietin-2 (Ang-2), a natural antagonist for Tie-2 that exerts its effects through an internal autocrine loop mechanism. In addition to suppressing endothelial cell activation by inhibiting the expression of adhesion and inflammatory molecules, Ang-1 enhances endothelial cell survival and capillary morphogenesis, and lessens capillary permeability. As such, Ang-1 has a potential to become an effective therapeutic agent for treating various endothelium disorders, including several severe human pulmonary diseases. The efficacy of cell-based Ang-1 gene therapy for acute lung injury (ALI) has recently been studied in a rat model of ALI (1). The results of this study show that such therapy can markedly improve lung condition and suggest that Ang-1 therapy may represent a potential new strategy for the treatment and/or prevention of acute respiratory distress injury (ARDI), a significant cause of morbidity and mortality in critically ill patients. Recombinant human ANG-1, derived from HeLa cells, is a C-terminal histidine tagged glycoprotein which migrates with an apparent molecular mass of 60.0 – 70.0 kDa by SDS-PAGE under reducing conditions. Sequencing analysis shows N-terminal sequences starting with Ser-20 and with Asp-70 of the 498 amino acid precursor protein.

    Catalog #:

    130-06

    Source :

    HeLa cells

    Stability :

    The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted ANG-1 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles.

    Purity :

    Greater than 95% by SDS-PAGE gel and HPLC analyses.

    Endotoxin Level :

    Endotoxin level is less than 0.1 ng per μg (1EU/μg).

    Biological Activity :

    Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC).

    Selected References :

    Selected List of References Citing This PeproTech Product

    PubMed Link :

    Angiopoietin-1

    Country of Origin :

    USA

     

     

    滬公網安備 31011402005168號

    欧美精品专区高清在线爱美_香蕉久久一区二区不卡无毒影院_亚洲精品国产福利在线观看_久久AV无码精品人妻系列果冻
    <ruby id="zqerw"><i id="zqerw"><strike id="zqerw"></strike></i></ruby>
  • <small id="zqerw"><del id="zqerw"></del></small>